Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2003
03/25/2003US6538119 Nucleotide sequences for use in the classification, diagnosis, prevention, imaging and treatment of mammary gland defects
03/25/2003US6538114 Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen
03/25/2003US6538111 Monoclonal, humanized antibodies; hybridomas; transformants; use in diagnosis and treatment of chronic bronchial asthma
03/25/2003US6538109 Polynucleotide compositions encoding broad spectrum delta-endotoxins
03/25/2003US6538104 Stabilization of cardiac troponin I subunits and complexes
03/25/2003US6538103 Anti-angiogenic agents; kringle 1; use treatment of cancer, diabetic retinopathy, rheumatoid arthritis, psoriasis, arteriosclerotic plaque formation
03/25/2003US6537972 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
03/25/2003US6537966 Follistatin-3
03/25/2003US6537965 Novel parathyroid hormone (PTH) peptide derivatives. In particular, the invention relates to PTH PTH-2 receptor agonist or antagonist properties to the derivatives.
03/25/2003US6537815 Method of altering the expression of csrB to modify the properties of a cell
03/25/2003US6537812 Methods for the production of TcRγδ+ T cells
03/25/2003US6537809 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
03/25/2003US6537808 Preservation of eye tissues in culture; obtain tissue, mix with nutrient broth, monitor stability of sample and cultures
03/25/2003US6537807 Cells designated CD7+CD34-Lin-; use in treatment of genetic and infectious diseases; identification of substances to promote growth, engraftment, and differentiation of stem cells
03/25/2003US6537806 Compositions and methods for treating diabetes
03/25/2003US6537805 Self-deleting vectors
03/25/2003US6537804 Expression vector comprising a DNA sequence that expresses a peptide of given amino acid sequence which includes tyrosine; use in diagnosis and treatment of leukemia
03/25/2003US6537794 Chemokine
03/25/2003US6537793 Method of separating viral particles
03/25/2003US6537785 Methods of treating lysosomal storage diseases
03/25/2003US6537784 Self-regulated apoptosis of inflammatory cells by gene therapy
03/25/2003US6537782 Comprising enzymatic degradation product of fish meat or a fish meat extract; not containing mammal-derived components
03/25/2003US6537779 T7 promoter-based expression system
03/25/2003US6537776 Synthetic ligation reassembly in directed evolution
03/25/2003US6537775 Gene involved in cadasil, method of diagnosis and therapeutic application
03/25/2003US6537773 Open reading frames; gene expression; genetic vectors; computer based storage of sequence information; use detection and diagnosis of Mycoplasma
03/25/2003US6537765 GPR10 as a target for identifying weight modulating compounds
03/25/2003US6537764 Method of identifying inhibitors of C—C chemokine receptor 3
03/25/2003US6537763 Nucleotide sequences coding binding protein for use used in controling immune response and screening for modulators of receptor activity
03/25/2003US6537756 Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and Ctenocephalides SPP
03/25/2003US6537750 Plant regulatory elements that can be used to express various nucleic acid molecules in transgenic plants
03/25/2003US6537567 Tissue-engineered tubular construct having circumferentially oriented smooth muscle cells
03/25/2003US6537560 Nucleic acid sequences encoding melanoma antigens recognized by T lymphocytes and protein and peptides encoded by these sequences
03/25/2003US6537540 Administering recombinant adeno-associated virus vector; polynucleotide encoding fusion polypeptide with extracellular domain of the TNF receptor and a constant domain of an IgG1 molecule
03/25/2003CA2399569A1 Diagnostic markers and drug targets for treatment of cancer
03/25/2003CA2274092C Gene-trapping construct for the identification and isolation of genes
03/25/2003CA2251262C Nucleic acid encoding a nervous tissue sodium channel
03/25/2003CA2224093C Human vascular endothelial growth factor 2
03/25/2003CA2125783C Methods for producing thrombin
03/25/2003CA2123108C Human neuropeptide y-y1 receptor
03/25/2003CA2075182C Retinoid receptor compositions and methods
03/25/2003CA2056102C Method for the production of antibodies
03/20/2003WO2003023642A2 Arrangement with artificial neurons for describing the transmission behavior of a nerve cell to be excited and method for determining the transmission behavior of a nerve cell to be excited using artificial neurons
03/20/2003WO2003023404A1 A method of diagnosis and treatment and agents useful for same
03/20/2003WO2003023048A2 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l)
03/20/2003WO2003023042A1 Recombinant mva capable of expressing structural hcv antigens
03/20/2003WO2003023040A2 Vaccinia virus mva-e3l-knockout-mutants and use thereof
03/20/2003WO2003023028A1 Fungal glyoxal oxidases
03/20/2003WO2003023026A1 Alphavirus replicon vector systems
03/20/2003WO2003023025A1 Multiplication of viruses in a cell culture
03/20/2003WO2003023023A1 Production and use of human cd124 and cd116 positive tumour cell lines in the production of allogenic or semi-allogenic immunotherapy agents
03/20/2003WO2003023022A2 Method to induce the differentiation of endothelial cells to cardiomyocites
03/20/2003WO2003023021A2 Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture
03/20/2003WO2003023020A1 Pancreatic small cells and uses thereof
03/20/2003WO2003023019A1 Methods and cell cultures for promoting organogenesis and tissue development
03/20/2003WO2003023018A2 A method for isolating, culturing and differentiating intestinal stem cells for therapeutic use
03/20/2003WO2003023014A2 Human ion channels
03/20/2003WO2003023010A2 Sensory neuron receptors
03/20/2003WO2003023008A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003WO2003023006A2 Hemocyanin nucleic acids and polypeptides and related vectors, fusion proteins, conjugates, cells and methods of use
03/20/2003WO2003023004A2 Antisense modulation of fibroblast growth factor receptor 3 expression
03/20/2003WO2003023001A2 Novel proteins and nucleic acids encoding same
03/20/2003WO2003022995A2 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003WO2003022988A2 Adipose-derived stem cells and lattices
03/20/2003WO2003022985A2 Method and structure for growing living organic tissue
03/20/2003WO2003022885A1 Chemokines
03/20/2003WO2003022880A2 Synthetic hcv envelope proteins and their use for vaccination
03/20/2003WO2003022869A2 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof
03/20/2003WO2003022311A1 Adenoviral vector and related system and methods of making and use
03/20/2003WO2003022227A2 Antisense modulation of vascular endothelial growth factor receptor-1 expression
03/20/2003WO2003022222A2 Antisense modulation of protein kinase r expression
03/20/2003WO2003022215A2 Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response
03/20/2003WO2003022202A2 Compositions and methods for treatment of cancer
03/20/2003WO2003022126A2 Compositions and methods for the therapy and diagnosis of colon cancer
03/20/2003WO2003022125A2 Device and method to maintain vascularization near implant
03/20/2003WO2003022123A2 Methods of kidney transplantation utilizing developing nephric tissue
03/20/2003WO2003022043A1 Hair follicle-reconstitution system and animal carrying the same
03/20/2003WO2003022032A2 Method for increasing stress tolerance in plants
03/20/2003WO2003006055A8 Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit
03/20/2003WO2003000848A3 Liver engrafting cells, assays, and uses thereof
03/20/2003WO2002099075A3 Prmts as modifiers of the p53 pathway and methods of use
03/20/2003WO2002098361A3 T cell induced tissue repair and regeneration
03/20/2003WO2002097065A3 Remodeling of somatic nuclei upon addition of pluripotent cell extracts
03/20/2003WO2002096364A3 Feline bronchioloalveolar lung carcinoma xenograft and cell line
03/20/2003WO2002092792A3 Antigen-dependent reduction of specific immune responses by influencing co-stimulation
03/20/2003WO2002092786A3 A helper dependent adenoviral vector system and methods for using the same
03/20/2003WO2002088340A3 Alkaline protease variants and detergents and cleaning agents containing said alkaline protease variants
03/20/2003WO2002085285A3 Methods and reagents for regulating bone and cartilage formation
03/20/2003WO2002079404A3 Cytoskeleton-associated proteins
03/20/2003WO2002074045A3 Production of pancreatic islet cells and delivery of insulin
03/20/2003WO2002072602A3 Somatostatin antagonists
03/20/2003WO2002068603A9 Materials and methods for the induction of premature chromosome condensation
03/20/2003WO2002053733A3 Regulation of human b7-h2 protein
03/20/2003WO2002053728A3 Gene disruption methodologies for drug target discovery
03/20/2003WO2002050255A3 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof
03/20/2003WO2002046417A3 Adipocyte complement related protein zacrp3x2
03/20/2003WO2002046359A8 INDUCIBLE HIGHLY PRODUCTIVE rAAV PACKAGING CELL-LINES
03/20/2003WO2002038726A3 Paramyxovirus vector for gene transfer to the cardiovascular system
03/20/2003WO2002024897A9 Conditionally replicating viral vectors and their use
03/20/2003WO2002022809A9 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
1 ... 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 ... 1827